SPX3,640.47-78.57 -2.11%
DIA292.21-4.52 -1.52%
IXIC10,737.51-314.13 -2.84%

Genfit's Cholangiocarcinoma Therapy Candidate Secures US FDA Orphan Drug Designation

Genfit's Cholangiocarcinoma Therapy Candidate Secures US FDA Orphan Drug Designation

MT Newswires · 09/13/2022 12:45

Please log in to view news